retatrutide clinical trial south africa Oh we are patiently awaiting your arrival. On a more serious Tirzepatide after intensive lifestyle intervention

This is the worst the GLP drugs will ever be The smartest person I know in medicine, Dave Park, has told me the only reason surgeons ever have something to do is because medicine hasnt figured out how to solve the problem yet. And in that spirit, todays newsletter is about celebrating the advances in the field of the GLP drugs, which are solving a problem I didnt think medicine would ever solve: curing obesity and metabolic syndrome in our modern food and movement environment

This policy may change from time to time

Steady weight change : One to two pounds per week, or measurable changes in waist circumference

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: A meta-analysis

The insurance coverage situation makes optimizing every other aspect of your health protocol even more important

This article was originally published in PharmaCircle Weekly Intelligence